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The proepicardial organ is an important transient
structure that contributes cells to various cardiac
lineages. However, its contribution to the coronary
endothelium has been disputed, with conflicting
data arising in chick and mouse. Here we resolve
this conflict by identifying two proepicardial markers,
Scleraxis (Scx) and Semaphorin3D (Sema3D), that
genetically delineate heretofore uncharacterized
proepicardial subcompartments. In contrast to previ-
ously fate-mapped Tbx18/WT-1-expressing cells
that give rise to vascular smooth muscle, Scx- and
Sema3D-expressing proepicardial cells give rise to
coronary vascular endothelium both in vivo and
in vitro. Furthermore, Sema3D+ and Scx+ proepicar-
dial cells contribute to the early sinus venosus and
cardiac endocardium, respectively, two tissues
linked to vascular endothelial formation at later
stages. Taken together, our studies demonstrate
that the proepicardial organ is a molecularly com-
partmentalized structure, reconciling prior chick
and mouse data and providing a more complete
understanding of the progenitor populations that
establish the coronary vascular endothelium.
INTRODUCTION
The proepicardial organ (PEO) is a transient extra-cardiac cluster
of cells that arises as an outgrowth of the coelomic mesothelium
at the ventro-caudal base of the developing heart. Shortly after it
forms, cells from the PEO migrate away from the body wall and
onto the surface of the heart (Ishii et al., 2010; Ma¨nner, 1992;
Nahirney et al., 2003) where most of these cells will give rise to
the epicardium while a subset of them invade the underlying
heart tube and contribute to various lineages within the devel-
oping heart itself (Gourdie et al., 2000). Recently, the epicardiumDevelohas also been implicated as a resident progenitor cell population
for cardiomyocyte repair in adult tissues (Smart et al., 2011).
Lineage tracing studies have led to contradictory findings for
the fates of PEO cells. Although avian studies using diI labeling,
retroviral tracing, and quail-chick chimeras have established the
PEO as a source of both vascular smoothmuscle and endothelial
cells (Guadix et al., 2006; Ma¨nner, 1999; Mikawa and Gourdie,
1996; Gourdie et al., 2000; Pe´rez-Pomares et al., 2002), fate
mapping studies in mice have not identified a significant proepi-
cardial contribution to the endothelium (Cai et al., 2008; Zhou
et al., 2008). These previous fate maps in mouse, using the
well characterized proepicardial markers Tbox18 (Tbx18) and
Wilms Tumor-1 (WT-1), suggested that the PEO gives rise to
smooth muscle, myocardium, and fibroblasts but few or no
endothelial cells. In contrast, a recent study demonstrated that
some murine coronary endothelial cells arise from both the
endothelial lining of the sinus venosus (the main vein that returns
blood to the embryonic heart) and from the cardiac endocar-
dium, with no contribution to these structures from Tbx18+
proepicardial cells (Red-Horse et al., 2010).
In this study, we reconcile the apparently divergent findings
previously reported in mouse and chick. We demonstrate
that, despite being morphologically homogeneous, the PEO is
compartmentalized into genetically distinct subcompartments.
Inparticular, domainsmarkedbyexpressionof themarkersScler-
axis (Scx) and Semaphorin3D (Sema3D) are largely nonoverlap-
ping with Tbx18- and WT-1-expressing populations. Thus, the
previous mouse fate maps utilized genetic tools that mark only
a subset of proepicardial cells, thereby excluding important
domains of the proepicardium. Using fate mapping studies in
bothmouseandchick, aswell as in vitro analysis,wedemonstrate
that Scx and Sema3D lineage-traced proepicardial cells give rise
to endothelial cells, in addition to other cardiac fates. Additionally,
at E10.5 Sema3D lineage-traced proepicardial cells contribute to
the sinus venosus, whereas Scx lineage-traced proepicardial
cells contribute to cardiac endocardium, two tissues linked at
later stages to the development of the coronary endothelium.
Our study characterizes the PEO as a molecularly heteroge-
neous structure that contributes to the vascular endothelium inpmental Cell 22, 639–650, March 13, 2012 ª2012 Elsevier Inc. 639
Figure 1. Sema3D and Scx Mark Proepicardial and Migrating Epicardial Cells
(A–D) Radioactive RNA section in situ hybridization (ISH) of Sema3D in mouse embryos E9.5–E14.5. Sema3D is restricted to the proepicardium at E9.5 (A) and
migrating epicardial cells (B–D) until E12.5 after which expression can also be seen in the valve cushions (D).
(E–I) Bright field (E) and direct GFP fluorescence (F) in Sema3DGFPCre E9.5 mouse embryos. (G–I) Immunohistochemistry (IHC) with an anti-GFP antibody on
Sema3DGFPCre embryos. Sema3DGFPCre recapitulates endogenous Sema3D expression in the early proepicardium and epicardium (F–I).
(J) Whole-mount ISH of Scx in wild-type mouse embryos at E9.5.
(K and L) Section ISH to Scx (K) and Tbx18 (L) at E9.5. Scx is restricted to only a subdomain of the PEO as compared to Tbx18 that is expressed throughout the
PEO and extends into the septum transversum (notched arrow in L).
(M and N) RNA ISH to Scx in E10.5 wild-type mouse embryos (M) and at higher magnification (N).
(O–Q) IHC with an anti-GFP antibody in ScxGFPmouse embryo sections, E10.5–E12.5. Scx expression is restricted to the proepicardium and epicardium prior to
E11.5 when it comes on only in the developing valves (notched arrow in P and Q). By E12.5, Scx is largely gone from the epicardium (Q). A/V, atrium/ventricle; EP,
epicardium; LV/RA, left/right atrium; LV/RV, left/right ventricle; PE, proepicardium. See also Figure S1.
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a more complete understanding of the progenitor populations
that give rise to the coronary vasculature.
RESULTS
Scx and Sema3D Mark Proepicardial and Epicardial
Development
In the course of other studies, we observed strong expression of
bothScx andSema3D in the early and developing PEO (Figure 1).640 Developmental Cell 22, 639–650, March 13, 2012 ª2012 ElsevierThese expression domains in the PEO were faithfully recapitu-
lated, respectively, by a previously characterized ScxGFP
transgenic line (Pryce et al., 2007; Levay et al., 2008), and by
aGFPCre fusion knock-in into the first coding exon of the endog-
enous Sema3D locus (see Figure S1 available online). After con-
firming that they mark the same cell populations in the heart as
detected by in situ hybridization, these lines were used for
subsequent visualization of expression domains. Scx expression
is first noted in the bilateral anlagen of the developing PEO at
E9.0, whereas Sema3D expression is first detected in the PEOInc.
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sion extends to either the septum transversum, the endocardial
cushions, or both (Figure 1L), in situ analysis reveals that Scx and
Sema3D expression are restricted, within the heart, to only
proepicardial cells and migrating epicardial cells prior to E11.5
(Figure 1 and Figures S1 and S2).
Although both of these genes mark the PEO and early epicar-
dium they begin to differ in their temporal expression by E12.5.
At E12.5 Scx expression is greatly decreased in the epicardium
(Figure 1Q), and by E13.5 it is undetectable by in situ hybridiza-
tion (data not shown). In contrast, strong epicardial expression of
Sema3D persists beyond E14.5 (Figure 1I).
To assess the spatial overlap of these genes, previously
characterized ScxAP transgenic mice (Pryce et al., 2007) were
crossed to Sema3DGFPCre mice. Immunohistochemistry (IHC)
for AP and GFP revealed that although Scx and Sema3D repre-
sent partially overlapping populations they are not entirely
congruent (Figures S2A–S2C).
The Proepicardium Is a Heterogeneous Structure
with Genetically Distinct Subcompartments
Two additional markers, Tbx18 andWT-1, have been previously
reported to label proepicardial cells (Kraus et al., 2001; Zhou
et al., 2008). We examined the relative expression domains of
Scx, Sema3D, Tbx18, and WT-1 in the PEO at E9.5 (Figure 2).
Intriguingly, we found that the expression domains of both Scx
and Sema3D are largely distinct from those of Tbx18 andWT-1.
In the case ofSema3D, antibodies toGFP, Tbx18, andWT-1were
used to stain histological sections from E9.5 Sema3DGFPCre mice
revealing that many Sema3D+ proepicardial cells do not express
either Tbx18 or WT-1. Manual quantification revealed that only
29% (140/486) of Sema3D-expressing proepicardial cells coex-
press either Tbx18 or WT-1, whereas 71% (346/486) singularly
express Sema3D (n = 3 averaged) (Figures 2A–2F). Likewise,
E9.5 ScxGFP embryos were assayed by co-IHC to GFP and
WT-1, revealing that many Scx-expressing cells are distinct
fromWT-1 expression (Figures 2G–2I). To assess the relationship
between Scx and Tbx18 expression, ScxGFPmice were crossed
to Tbx18nLacZ knock-in mice (previously denoted Tbx18-floxed
nLacZ/nGFP (Cai et al., 2008)) and embryos were assayed for
expressionofGFPandLacZatE9.5 (Figures2J–2L). LikeSema3D
cells,Scx-expressingcells are largelydistinct fromthoseexpress-
ing Tbx18. Of an average 556 Scx-expressing cells per PEO, only
33.1% (184/556) coexpressed either Tbx18 or WT-1, whereas
66.9% (372/556) singularly expressed Scx (n = 3, averaged).
To further confirm the genetic distinction between Scx and
Tbx18, previously characterized ScxGFPCre BAC transgenic
mice (Blitz et al., 2009) (Figures S2D–S2O) were crossed to
mice harboring a floxed nLacZ allele driven from the Tbx18
promoter (denoted Tbx18floxednLacZ) (Cai et al., 2008). In
Tbx18floxednLacZ embryos, all Tbx18-expressing cells should
express LacZ unless a Cre mediated recombination event
occurs. Therefore, in the presence of ScxCre, only Tbx18-
expressing cells that have never expressed ScxCre retain their
LacZ expression. To quantify the relative overlap of Tbx18
expression with that of ScxCre, serial sections were manually
quantified from Tbx18floxednLacZ embryos (n = 4, averaged)
and compared to ScxCre;Tbx18floxednlacZ embryos in which
cells that express both ScxCre and Tbx18floxednlacZ shouldDevelohave lost expression of the lacZ reporter cassette (n = 4,
averaged). Even as late as E12.5, 49% of Tbx18-expressing
epicardial cells in ScxCre;Tbx18floxednlacZ embryos retain their
lacZ expression (Figures 2M–2Q), indicating that these Tbx18-
expressing cells have never expressed ScxCre. Taken together,
our results indicate that Scx and Sema3D identify distinct popu-
lations of proepicardial cells including many that would have
been overlooked during previous attempts to determine epicar-
dial-derived lineages using Tbx18 or WT-1 as genetic markers
(Cai et al., 2008; Zhou et al., 2008).
Scx and Sema3D Lineage-Traced Cells Differ in Their
Relative Contributions to Downstream Fates
The fact that Scx and Sema3D expression mark only partially
overlapping subpopulations raised the possibility that these
subcompartments could give rise to descendants with distinct
cell fates. To explore this possibility, we crossed the ScxGFPCre
and Sema3DGFPCre lines separately to the lineage reporter
R26RLacZ (Soriano, 1999). Sections were analyzed for b-galacto-
sidase activity (identifying Scx or Sema3D descendants) by
X-gal staining and by IHC to identify different cell types from
E9.5–E14.5 (Figure 3).
As noted previously, and consistent with previous studies
(Levay et al., 2008), Scx and Sema3D expression were not
observed in any cells within the heart prior to E11.5, at which
point Scx expression is restricted to the endocardial cushions
(Figure 1P) (Levay et al., 2008), followed by expression of
Sema3D only in the cushions at E12.5 (Figures 1C and 1D). Prior
to E11.5 their expression within the heart is restricted to only the
PEO and migrating epicardial cells (Figure 1 and Figures S1 and
S2). Hence LacZ expression within the heart during these stages
most likely reflects the migration of cells that previously ex-
pressed Scx or Sema3D, respectively, outside of the heart
rather than de novo expression within it.
In keeping with their endogenous expression, lineage-traced
cells of both populations are identified in the PEO at E9.5 and
are present in a mosaic pattern throughout the epicardium by
E10.5 (Figures 3A, 3B, and 3N). However, these two populations
differ in the timing of their entrance into the heart as well as their
relative contributions to downstream lineages.
Sema3D-lineage derived cells are first identified within the
heart at E12.5 adjacent to the epicardial surface in the region
of the left ventricle and interventricular septum (Figure 3C and
inset) despite the absence of any active expression in this tissue.
By E14.5, many Sema3D-derived cells are found in the heart,
with an epicardial-to-endocardial gradient (Figure 3D). In
contrast to Tbx18 and WT-1, Sema3D lineage derived cells
were observed to only rarely give rise to cardiomyocytes by
E16.5, with manual quantification identifying fewer than 0.36%,
or 18/5,000 Sema3D lineage-traced cells coexpressing Cardiac
Troponin T by E16.5 (Figures 3E–3J and Table S1). In contrast,
410/4,400, or 9.3% of Sema3D derivatives that give rise to
smooth muscle as indicated by coexpression of the smooth
muscle marker SM22 (Figures 3K–3M). Sema3D derived cells
were also noted to give rise to fibroblasts (Figures S3A–S3C).
Like Sema3D, Scx lineage-traced cells are visible in a mosaic
pattern in the epicardium beginning at E10, yet in contrast to
Sema3D, Scx lineage-traced cells are present in the heart walls
as early as E10.25–10.5 in cells adjacent to the epicardiumpmental Cell 22, 639–650, March 13, 2012 ª2012 Elsevier Inc. 641
Figure 2. Sema3D- and Scx-Expressing Proepicardial Subdomains Are Largely Distinct from Tbx18 and WT-1 Expression
(A–F) Magnified view of the PEO of Sema3DGFPCre E9.5 mouse embryos with IHC to GFP (A,D), WT-1 (B) and Tbx18 (E). The merged view of GFP andWT-1 (C) or
Tbx18 (F) is shown. A portion of Sema3D-expressing proepicardial cells are distinct from theWT-1- and Tbx18-expressing populations, as depicted by the green
arrows. Red arrows represent cells expressing only WT-1(C) or Tbx18 (F). Yellow arrows represent cells that are double positive.
(G–L) Proepicardia of ScxGFP E9.5 mouse embryos with IHC to GFP (G,J), WT-1 (H), and Tbx18 (K). Merged images (I and L) show that Scx expression is
restricted to a subdomain largely distinct from WT-1 or Tbx18. Arrows represent single positive or double positive cells as described above.
(M and N) IHC to b-galactosidase on Tbx18floxednLacZ mice at E12.5; (N) shows higher magnification of (M).
(O and P) IHC to b-galactosidase on Tbx18floxednLacZ;ScxCre mice at E12.5; (P) shows higher magnification of (O).
(Q) By E12.5, 49% of Tbx18-expressing cells have never coexpressed Scx. Error bars represent the mean ± SD, p% 0.05. RA/LA, right/left atrium; RV/LV, right/
left ventricle. See also Figure S2.
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ventricle and are present in increasing numbers through E12.5
(Figures 3N–3Q) with cells visible in both ventricles by E13.5
(data not shown).642 Developmental Cell 22, 639–650, March 13, 2012 ª2012 ElsevierWhen we examined the cell types that arise from this lineage
of former Scx-expressing proepicardial cells, we observed that,
like the previously described Tbx18 and WT-1 derived cells,
Scx lineage-traced cells give rise to cardiomyocytes at E10.5Inc.
Figure 3. Sema3D and Scx Lineage Tracing
in the Embryonic Heart
(A–D) Section X-gal staining of Sema3DGFPCre;
R26RLacZ embryonic hearts, E9.5–E14.5. Migrat-
ing epicardial cells are seen on the surface of the
heart at E10.5 (B) with cells first noted within the
heart in the interventricular septum at E12.5
(C, inset) and spread throughout all four cham-
bers (D, inset) and developing vasculature (black
arrows in inset) by E14.5.
(E–J) Coimmunostaining with b-gal as a marker of
Sema3D lineage-traced cells (E), (H) inset, and
cardiac troponin T (F); (I, inset) at E14.5 and E16.5.
Themerged images (G, J inset) show that Sema3D
lineage-traced cells give rise to cardiomyocytes.
Shown here are double positive cells in the
right ventricle. Note the developed sarcomere
morphology in (J). Bright yellow cells in (G), lower
magnification) are autofluorescent red blood cells.
(K–M) Coimmunostaining with b-gal (K) and
smooth muscle actin (L) at E14.5 shows that
large numbers of Sema3D lineage-traced cells
give rise to vascular smooth muscle cells (merged
image in M).
(N–Q) Section X-gal staining of ScxCre;R26RLacZ
mouse embryos E10-E12.5. Scx lineage-traced
cells are present on the surface of the heart at E10
(N) and by E10.5 are observed within the heart.
(R–T) Coimmunostaining with b-gal (R) and
Cardiac Troponin T (S) shows that Scx lineage-
traced cells contribute to the cardiomyocyte
lineage (merged image shown in T).
(U–W) Coimmunostaining with b-gal (U) and
smooth muscle myosin (V) reveals that unlike
Tbx18, WT-1, and Sema3D, Scx lineage-traced
cells do not contribute in large quantities to the
smooth muscle fate by E13.5 (merged image in W)
though contribution is observed at later stages.
A/V, atrium/ventricle; PE, proepicardium; RA/LA,
right/left atrium; RV/LV, right/left ventricle. See
also Figure S3.
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Proepicardium-Derived Vascular Endothelial Cells(Figures 3R–3T). By E14.5, small numbers of Scx lineage-traced
myocytes are normally distributed throughout the heart as
indicated by immunostaining with Cardiac Troponin T (cTnT)
and Connexin 43 (Cx43) (Figures S3D and S3E).Developmental Cell 22, 639–65However, in contrast to Tbx18 (Cai
et al., 2008) and WT-1-derived cells
(Zhou et al., 2008) and the Sema3D-
derived cells described above, Scx
lineage-traced cells only rarely express
smooth muscle markers prior to E13.5
(Figures 3U–3W). Colocalization of these
signals is noted more frequently begin-
ning at E14.5 when active expression of
Scx is noted in the smooth muscle of
the aorta and pulmonary artery (Figures
S3F–S3J). Additionally, some fibroblasts
were noted to arise from Scx lineage-
traced cells (Figures S3K–S3M). To
quantify the relative contribution of Scx
lineage-traced cells to these fates post-natally, ScxCre;R26Rtdtomato lineage-traced hearts were isolated
frommouse pups on postnatal day 4 and treated with antibodies
to troponin T and smooth muscle myosin. Analysis by FACS
indicated that 6.6% of Scx lineage-traced cells (1,755/26,2910, March 13, 2012 ª2012 Elsevier Inc. 643
Figure 4. Endothelial Cells Derive from
Sema3D and Scx Lineage-Traced Proepi-
cardial Cells
(A–F) Coimmunostain of Flk-1 (A) and Pecam-1 (D)
with b-gal (B,E indicating Sema3D lineage-traced
cells) in Sema3DGFPCre;R26RLacZ E14.5 vessels
shows that Sema3D lineage-traced cells give rise
to vascular endothelial cells. (C) The merged
image of (A) and (B). (F) The merged image of (D)
and (E). Notched arrows in (C) and (F) indicate
double positive cells. These images are from the
free wall of the right ventricle.
(G–H) The sinus venosus (SV) is morphologically
distinct by E10.5 (G), but immunostaining for GFP
on Sema3DGFPCre embryos shows no expression
of Sema3D in this structure (H).
(I–L) Sema3DGFPCre;R26RLacZ embryos with X-gal
stain of the SV (J) is a magnified view of the boxed
region in (I) and immunostaining with Pecam-1 (K)
and b-gal (L) on adjacent sections of the SV valve
leaflets shows that Sema3D lineage-traced cells
contribute to the endothelial lining of the SV (L,
notched arrows).
(M) X-gal stain of P5 hearts shows Sema3D
lineage-traced cells in the vascular tree.
(N) Transverse section of (M).
(O–T) Section immunostaining on ScxCre;
R26RLacZ hearts at E11.0. Immunostaining of Flk-1
(O) and Pecam-1 (R), b-gal (P,S, red cells) and
Nfatc1 (P,S, blue cells). Nfatc1 marks endocar-
dium, and is used for exclusionary purposes. (Q)
and (T) are merged composites of (O–P) and (R–S),
respectively. Notched arrows in (Q) and (T) show
that Scx lineage-traced epicardial cells give rise to
endothelial cells on the surface of the heart as
indicated by b-gal/Flk1 or b-gal/Pecam-1 double
positive stain and a lack of Nfatc1 staining. Addi-
tionally, notched arrow in (P) shows that a few
Scx lineage-traced cells colocalize with Nfatc1,
indicating that Scx lineage-traced cells can also
give rise to endocardial cells. EC, endocardium;
EP, epicardium; RA, right atrium; RV, right
ventricle; SV, sinus venosus; V, ventricle. See also
Figure S4.
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give rise to smooth muscle cells postnatally (Figures S4A
and S4B). The relative contributions of Scx and Sema3D
lineage-traced cells to various cardiac fates is summarized in
Table S1.644 Developmental Cell 22, 639–650, March 13, 2012 ª2012 Elsevier Inc.Scx and Sema3D Lineage-Traced
Cells Give Rise to Coronary
Endothelium
In addition to the cell fates described
above, our fate mapping studies of both
Sema3D and Scx proepicardial popula-
tions identified robust labeling of coro-
nary endothelium (Figure 4). Although
active expression of Scx or Sema3D
was not observed to colocalize with
endothelial markers within the proepicar-
dium (Figures S4D and S4E) each of
these proepicardial progenitor popula-tions were noted to give rise to endothelial descendants within
the heart. In the case of Sema3D, coimmunostaining of the
endothelial markers Flk-1 (Figures 4A–4C) and Pecam (Figures
4D and 4F and Figures S4I–S4L) together with b-gal showed
that Sema3D derivatives contribute to endothelial cells by
Developmental Cell
Proepicardium-Derived Vascular Endothelial CellsE14.5. By E16.5, 6.9% (386/5,623) of Sema3D lineage-traced
cells give rise to endothelial cells as assessed by manual quan-
tification (Table S1).
Interestingly, Sema3D derivatives also populate the endo-
thelial lining of the sinus venosus (SV) by E10.5 (Figures 4G–
4L), a region previously implicated to contribute to coronary
endothelial cells 24 hr later, beginning at E11.5 (Red-Horse
et al., 2010). Importantly, Sema3D itself is not expressed in the
sinus venosus endothelium at E11.5 or prior (Figure 4H) with
no overlap of Sema3D and VE-Cadherin (expressed in the
endothelial lining of the SV) detectable at these stages (Figures
S4F–S4H), suggesting that these fate-mapped cells are derived
from the PEO.
In the case of Scx, coimmunostaining with b-gal, Flk-1 and
Pecam revealed that Scx lineage-traced cells give rise to a few
coronary endothelial cells as early as E11 with more abundant
detection as development continues (Figures 4O–4T and Figures
S4M–S4U). This is earlier than the time when coronary endothe-
lium derived from the sinus venosus was identified in a prior
report (Red-Horse et al., 2010). Importantly, consistent with
previous reports (Cossette and Misra, 2011; Kalman et al.,
1995; Red Horse et al., 2010) the endothelial cells that we
observed are first detected on the epicardial surface of the heart
and by E12.5, are present within the heart in an epicardial to
endocardial gradient. However, As Flk-1 and Pecam may also
mark endocardial cells (a population distinct from endothelial
cells) we sought to label endocardial cells for exclusionary
purposes. Because Nfatc1 is endocardial specific in the context
of cardiac development, an anti-Nfatc1 antibody was used to
confirm that b-gal+/Pecam+/Nfatc1 cells were in fact endothe-
lial (Figures 4P and 4S).
In addition to giving rise to endothelial cells, colocalization with
Nfatc1 showed that some Scx lineage-traced cells give rise to
small numbers of endocardial cells by E11 (Figures 4P and 4S),
another cell type that, like the sinus venosus, has been shown
to contribute to coronary endothelial cells at E12.5 (Red-Horse
et al., 2010; Nemer and Nemer, 2002). However, immunohisto-
chemistry suggests that this contribution comprises only a small
population of endocardial cells within the heart. This is not
surprising in that endocardial tubes are present within the heart
prior to the existence of the PEO, thus themajority of endocardial
cells likely arise from an alternative source. However, this small
contribution may represent an important transient link between
the PEO and the endothelial cell fate.
Given that endothelial cells have not previously been shown to
arise from the PEO in mouse, we wanted to confirm that the
lineage-traced cells that we detect do in fact arise from the
epicardial-expressing populations rather than from cardiac
endothelial cells themselves expressing Cre at subdetectable
levels. We therefore turned to quantitative PCR as a more sensi-
tive detection method. Ventricles from E12.5 wild-type embry-
onic hearts were dissociated and labeled with a biotinylated
anti-Pecam antibody to identify endothelial cells. These labeled
cells were then isolated by means of streptavidin conjugated
beads. Quantitative RT-PCR was performed to assess the
relative expression levels of Sema3D and Scx in the cardiac
endothelial cell population. For each of these markers, noncar-
diac expression in wild-type embryos was used as a positive
control, and absence of expression in E12.5 Scx/ andDeveloSema3D/ embryos was used as a negative control. We did
not detect Scx or Sema3D expression above negative control
levels within endothelial cells (Figures S1O and S2P).
Postnatally, Scx lineage-traced endothelial cells are present
primarily in the ventricles with only small numbers detected in
the atria. These cells contribute to both arteries and veins as
marked by neuropilin-1 and Ephrin B2 staining (Figures S4P–
S4U) with a preferred contribution to arterioles and venules.
To quantify the relative contribution of Scx lineage-traced
cells to the endothelium postnatally, ScxCre;R26Rtdtomato
lineage-traced hearts were isolated from mouse pups on post-
natal day 4 and treated with antibodies to Pecam and Nfatc1
(to label endocardial cells for purposes of exclusion). Quantita-
tive FACS analysis revealed a distinguishable population of
Scx+/Pecam+/Nfatc1 endothelial cells accounting for aminority
of all endothelial cells (Figure S4C and Table S1).
Cross-Species Transplantation Verifies the Ability of
Murine PEO Cells to Give Rise to Coronary Endothelium
In Vivo
In situ and immunohistochemical analysis of Scx and Sema3D
expression did not detect active expression of these markers
within the heart other than the cardiac valves prior to E12.5,
nor did we detect any leaky Cre expression (Figures S1 and
S2). This is critical to the interpretation that the LacZ-expressing
cells within the endothelium and other heart tissues prior to these
stages reflects cells exposed to ScxCre and Sema3DGFPCre
activity earlier, within the PEO. Nevertheless, to directly demon-
strate that PEO cells have the potential to differentiate into
endothelium, we isolated murine proepicardial cells and grafted
them into the developing chick heart to test their developmental
potential.
To satisfy ourselves that grafted cells would faithfully recapit-
ulate endogenous cell fate decisions, we examined the WT-1
proepicardial subpopulation that has been previously fate-
mapped.WT-1 lineage-traced cells do not commonly contribute
to the endothelium in mouse; however, they do contribute sig-
nificantly to smooth muscle (Zhou et al., 2008). We dissected
proepicardia from WT-1GFPCre mice at E9.5 (a time when the
only cells expressing GFPcre are within the proepicardial organ)
and isolated GFP-expressing cells via FACS. We then colabeled
these cells with diI. GFP+/diI labeled cells (1,000/specimen)
were grafted into Hamburger and Hamilton (HH) stage 16 chick
proepicardia in ovo (developmentally equivalent to E9.5 mouse
proepicardial development). Following a 72 hr reincubation
period, chick hearts were harvested at HH stages 26–28 and
examined for the presence of diI labeled cells, denoting cells of
mouse proepicardial origin. We detected no contribution of
WT-1 proepicardial cells to the endothelial cell fate (n = 0/13
transplants), although these cells often gave rise to smooth
muscle cells (n = 8/13) (Figures 5A–5D). These results are
consistent with previous in vivo WT-1 fate mapping studies
done in mouse (Zhou et al., 2008), suggesting that the murine
proepicardial cells faithfully differentiate in the chick heart
microenvironment.
We next turned to Scx and Sema3D labeled murine proepicar-
dial cells at E9.5. Each of these two populations was indepen-
dently isolated and separately transplanted into developing
chick hearts in ovo. In the case of Scx, the protocol followedpmental Cell 22, 639–650, March 13, 2012 ª2012 Elsevier Inc. 645
Figure 5. Mouse PEO Cells Can Give Rise to Endothelial Cells Both In Vivo and In Vitro
(A–D) Histologic sections through a chick heart transplanted with E9.5WT-1GFPmouse PEO cells. Prior to transplantation, mouse cells were colabeled with diI (A).
WT-1 transplanted cells do not express Pecam-1 (B) but do express smooth muscle myosin (C). Merged image shown in (D).
(E–H) Transplants with E9.5 proepicardia from ScxGFPmice. DAPI staining of a chick ventricle is shown in (E). Prior to transplantationmouse cells were colabeled
with diI (F). Transplanted Scx + PEO cells give rise to endothelium as marked by Pecam-1 (G). Merge of diI and Pecam shown in (H). Insets in (F–H) show higher
magnifications of the boxed regions.
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stages 26–28, small numbers of DiI labeled cells were noted both
in the epicardium and within the heart (Figures 5E and 5F). The
presence of diI+/Pecam+ cells in 7/11 viable transplants
confirmed the ability of Scx PEO derived cells to assume an
endothelial cell fate in vivo (Figures 5G and 5H). The murine
proepicardial origin of these cells is further validated by the
fact that anti-Pecam antibodies do not cross react with chick
endothelial cells.
Similar transplants were performed to confirm the ability of
Sema3D proepicardial cells to give rise to endothelial cells.
Because we are unable to efficiently sort the Sema3D cells due
to weak fluorescence of GFP in the targeted mice, we instead
harvested the proepicardia from E9.5 Sema3DCre/+; Z/EG mice
that permanently express GFP following a Cre recombination
event. Two to three proepicardia were transplanted into each
stage 16 (HH) chick embryo and reincubated until stages 26–
28 (HH). Pecam positive cells were observed in four of five viable
transplants. Colocalization of GFP and Pecam confirmed the
ability of Sema3D lineage-traced proepicardial cells to give rise
to an endothelium (Figures 5I–5L). Additionally, in both the
Sema3D and Scx transplants, some vessels of mixed chick-
mouse origin were noted. Together, these results indicate that,
unlike the cells of the WT-1-marked compartment, the Scx
and Sema3D-expressing cells in the proepicardium have the
potential to differentiate into endothelial cells.
Proepicardial Cells Are Competent to Differentiate
into Endothelial Cells In Vitro
To further verify the developmental capability of murine PEO
cells to give rise to endothelial descendants, proepicardia from
E9.5 ScxGFP embryos were dissociated and, after FACS, the
GFP-expressing fraction was collected and cultured in vitro
under conditions previously reported to drive cells toward an
endothelial cell fate (Moretti et al., 2006). In parallel, the non-
GFP-expressing fraction of the proepicardium was collected
and cultured under matching conditions. After 7 days in culture,
42% of cells in the Scx enriched proepicardial fraction (51/121)
gave rise to endothelial cells as identified by anti-Pecam anti-
body staining. In addition, 16% of the non-Scx-expressing cells
(16/99) gave rise to endothelial cells under these conditions
(Figures 5M–5O). This result is not surprising in as much as
Scx and Sema3D mark only partially overlapping populations.
It is notable, however, that the Pecam positive cells in the Scx
enriched fractions were, on average, more highly developed
and more closely resembled appropriate endothelial cell
morphology than those marked in the non-Scx-expressing
fraction.
DISCUSSION
Here, we describe expression of Scx and Sema3D, two markers
of proepicardial and epicardial development. Our in situ and(I–L) Transplants from Sema3DGFPCre+;Z/EGmice. DAPI staining of the chick atrio
recombination at E9.5 (J). These cells are detected within the heart and are seen
(M–O) E9.5 Scx-expressing PEO cells can give rise to endothelial cells in culture as
and a Scx fraction (N). Comparative quantification of each fraction is shown in (O
ventricle.
Develoimmunohistochemical characterization shows that each of these
markers identifies a population of cells largely distinct from
Tbx18 and WT-1. These results indicate that, based on gene
expression, there are several molecularly distinguishable cell
populations within the developing PEO. We next used recombi-
nase-based fate mapping under the control of two independent
Cre driver mouse lines to study the cell types derived from the
Scx- and Sema3D-expressing PEO cells. The differences in
cell fates between the Tbx18 andWT-1, Scx, and Sema3D cells
indicate that these represent distinct, functionally significant,
subpopulations. Moreover, the finding that both the Scx and
Sema3D populations contribute to the endothelial lineage recon-
ciles previous chick andmouse fate mapping data that have until
now been contradictory. In particular, studies in avian species
have suggested that proepicardial cells may give rise to endo-
thelial cells (Gittenberger-de Groot et al., 1998; Reese et al.,
2002) but the previous fate maps in mice have failed to confirm
this data (Cai et al., 2008; Zhou et al., 2008). This seeming
disparity arose because prior avian studies, by the techniques
utilized, labeled cells throughout the proepicardium whereas
the previous murine studies focused on what we now conclude
to be restricted subpopulations that provide little or no endothe-
lial contribution.
The cardiac endocardium and the venous endothelium of the
sinus venosus could potentially represent independent sources
of coronary endothelial cells to those identified in our studies.
However, our fate mapping data indicate that by E10.5 Sema3D
lineage-traced cells contribute to the sinus venosus, whereas
Scx lineage-traced cells contribute to the cardiac endocardium
by E11 in the absence of any active expression of either of these
markers within these tissues. Previous studies have timed the
contribution from the sinus venosus beginning primarily at
E11.5 and that of the endocardium at E12.5 and later (Red-Horse
et al., 2010), 24–48 hr later than Scx or Sema3D proepicardial
cells have begun to contribute to these tissues. Therefore, our
data are consistent with the possibility that some Scx/Sema3D
precursors traverse through the sinus venosus endothelium
en route to the heart and/or transiently contribute to the endo-
cardium before entering the coronary vascular endothelial
lineage. It is possible that previous studies of the sinus venosus
and endocardium may have unknowingly included cells that
originate in the proepicardium while inadvertently overlooking
proepicardial derivatives that failed to express Tbx18 or WT-1.
At the same time, our observation that Scx lineage-traced cells
express endothelial markers on the epicardial surface of the
heart at E11, prior to any sinus venosus contribution, suggests
that some coronary endothelium derived from the proepicardium
arises via traditional routes of proepicardial migration (Cossette
and Misra, 2011; Hiruma and Hirakow, 1989; Komiyama et al.,
1987; Nahirney et al., 2003; Vira´gh and Challice, 1981).
In any recombinase-based fate mapping strategy, the con-
clusion reached depends upon the assumption that Cre is ex-
pressed only in the tissue being mapped. The possibility alwaysventricular sulcus (I). Sema3D lineage-traced cells express GFP following Cre
to coexpress Pecam-1 (K). Merged image of (J) and (K) shown in (L).
indicated by Pecam-1 expression. The PEOwas sorted into a Scx+ fraction (M)
). Error bars represent the mean ± SD; p% 0.05. AVS, atrioventricular sulcus; V,
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levels in other locations relevant to the mapping, in our case
within the heart itself or alternative tissues that contribute to
the heart. Despite careful expression analysis by ISH, IHC, and
qPCR, we cannot rule out the formal possibility that Sema3D
or Scx are expressed at subdetectable, yet nonetheless sig-
nificant, levels within relevant tissues. Additionally, at later time
points, both lines express in other tissues within the embryo
and we cannot technically eliminate the possibility that some
other source of Scx- or Sema3D-expressing cells gives rise to
a population in the heart. However, the pattern of expression
that we observe in innumerable sections from staged embryos
strongly suggests an origin from the epicardial surface with
subsequent epicardial-to-endocardial migration. If the cells orig-
inated in pharyngeal mesenchyme, for example (as do second
heart progenitors or those expressing Isl1Cre or Mef2c-AHF-
Cre), then they would be expected to migrate to the ventricles
via the anterior or posterior poles of the heart, and we would first
identify these indelibly labeled cells in the outflow or inflow tracts.
But this is not the pattern that we see. If the labeled cells origi-
nated via the circulation from a distant site, then we would
expect to see them first on the endocardial surface, or adjacent
to coronary vessels, but we do not. The earliest endothelial cells
that we mark are first noted directly on the epicardial surface of
the heart at E11 and derive from lineage-traced epicardial cells.
For these reasons, we believe our data strongly support the
conclusion that the labeled cells arise from the PEO.
Because an endothelial lineage had not previously been re-
ported to arise from the PEO in mice, we sought to verify the
competence of murine PEO cells to contribute to coronary endo-
thelium in two ways: mouse to chick proepicardial transplants as
well as an in vitro cell culture assay. In both experiments we
utilized PEO cells that actively express Scx or Sema3D at E9.5,
hence in each case all endothelial cells that arose must have
originated from E9.5 mouse PEO cells. These experiments
confirm the competence of PEO lineage-traced cells to give
rise to endothelial cells both in vivo and in vitro. Furthermore,
mouse to chick proepicardial transplants utilizing WT-1-
expressing cells failed to give rise to endothelial cells but were
able to give rise to smooth muscle cells as marked by smooth
muscle markers. This important control supports the notion
that the PEO is comprised of genetically distinct subcompart-
ments that differ in their downstream fates.
In addition to observing endothelial cells in our in vitro cultures
arising from the ScxGFP-expressing fractions, we also saw
smaller numbers of endothelial cells in cultures of GFP cells. A
likely explanation is that, given that the Scx- and Sema3D-
expressing PEO populations only partially overlap, the endo-
thelial cells in the GFP- fraction arise from the Sema3D cells
that were excluded during FACS. However, our results do not
rule out the possibility that there exist additional, as yet unchar-
acterized, subcompartments of the PEO that also have the
potential to give rise to endothelial cells. It is also possible that
known proepicardial populations (such as Tbx18 or WT-1) are
not restricted from the endothelial lineage whereas in the PEO
or in culture though their descendants become restricted from
the endothelial lineage in vivo.
These studies demonstrate and begin to define complex inho-
mogeneous populations of cardiac precursor cells within the648 Developmental Cell 22, 639–650, March 13, 2012 ª2012 ElsevierPEO. These genetically distinct subcompartments differ in both
the routes and the timing of their migration and also give rise
to distinct albeit overlapping cell fates, including contributions
to the vascular endothelium. Our results establish the complexity
of the PEO as a source of multiple progenitor populations while
simultaneously offering a more complete understanding of
the diversity of tissues that give rise to the coronary vascular
endothelium.EXPERIMENTAL PROCEDURES
Mice
Wild-type analysis was performed on C57BL6 mice (Charles River Labo-
ratories). ScxGFP (Pryce et al., 2007), R26Rtdtomato (Madisen et al., 2010),
Rosa26LacZ (Soriano, 1999), and Tbx18:nLacZ/nGFP (Cai et al., 2008) have
been described. For details on the generation of Sema3DeGFPcre knock in
mice and ScxGFPCre BAC transgenic mice see Supplemental Experimental
Procedures. All mouse work at Harvard University and the University of Penn-
sylvania was performed according to each respective institution’s university
animal care guidelines. This work was overseen by the institutional Review
Boards of Harvard University and the University of Pennsylvania.
Immunostaining
Embryos were dissected in PBS and either transferred immediately to 30%
sucrose or fixed in 4% paraformaldehyde for 15 min–2 hr at 4C. Whole mount
hearts were washed 3 3 10 min in PBS and incubated with anti-b-galactosi-
dase antibodies. Embryos were transferred to 30% sucrose for 4 hr-overnight
at 4C. Embryos were embedded on OCT (TissueTek) and cut by cryosection-
ing (7–10 and 80 um). Sections were rehydrated in PBS or TBS, incubated
in blocking solution for 1 hr (5% donkey serum in PBS + 0.1% Triton-X) and
incubated with primary antibodies in PBS + 0.1% Triton-X or TBS (without
Triton-X) overnight at 4C. Sections were then washed in PBS-Triton or TBS
and incubated with fluorescent conjugated secondary antibodies (1:500) for
2 hr at room temperature. For a complete list of primary antibodies used see
Supplemental Experimental Procedures.
RNA In Situ Hybridization
Radioactive in situ hybridization was performed for Sema3D on paraformalde-
hyde-fixed, paraffin- embedded sections according to standard protocols
(Singh et al., 2010). A 676-bp long in situ probe was generated containing
the 3-untranslated region of the mouse Sema3D gene. The following primers
were used to generate this fragment: forward, CAGTACTGTG AGCAGATGTG;
reverse, CATTACTGCAGTACACTAGATG. Colorimetric whole mount and
section in situ hybridizations for Scx were carried out as previously described
(Brent et al., 2003; Murtaugh et al., 1999). Colorimetric sections shown at time
points up to E9.5 were stained in whole mount and sectioned following
staining. Some in situs at E10.5 and later were performed on ScxGFP+/
embryos in addition to wild-type embryos.
Xgal Staining
Timed pregnant embryos were harvested in PBS and fixed in either ice cold
4% paraformaldehyde for 15–60 min at 4C, or in 25% glutaraldehyde in
PBS for 10–20min at room temperature. Staining was performed as previously
described (Cai et al., 2008).
Endothelial Bead Isolation
E12.5 wild-type hearts were harvested into PBS and then transferred to
PBS + 20% fetal bovine serum + Roche Collagenase A 10 mg/ml + Roche
collagenase B 10 mg/ml and incubated at 37C for 1 hr with manual tituration
every 15 min. Cells were pelleted and resuspended in TBS. Following disso-
ciation, endothelial cells were labeled with biotinylated Rat Anti-Mouse CD31
(BD Pharmingen, catalog #553371) antibody and then isolated according to
manufactures instructions using CELLection biotin binder kit (Invitrogen,
catalog #115.33D) or MagPrep Streptavidin beads (Novagen, catalog
#70716).Inc.
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Quantitative PCR was performed as previously described (Singh et al., 2010,
2011). Briefly, total RNA was isolated from E12.5 wild-type embryos,
Sema3D-knockout embryos, Scx knockout embryos, and endothelial cells
isolated from E12.5 wild-type hearts, using TRIzol (Invitrogen). RNA was
reverse-transcribed using random hexamers and the SuperScript First
Strand Synthesis kit (Invitrogen). Gene expression was measured by quantita-
tive RT-PCR (ABI PRISM 7900) using SYBR Green master mix (Applied
Biosystems). Signals were normalized to corresponding GAPDH controls.
PCR conditions and primer set sequences are available upon request.Mouse-to-Chick Proepicardial Transplants
For transplantation of Scx- and WT-1-expressing cells, proepicardia were
dissected from ScxGFP or WT-1GFPCre embryos at E9.5. Proepicardia were
dissociated (PBS + 20% fetal bovine serum + Roche Collagenase A
10 mg/ml + Roche collagenase B 10 mg/ml) and incubated at 37C for
1 hr with manual tituration at 15-min intervals. Dissociated cells were FACS
sorted to isolate GFP+ cells. GFP+ cells were treated with CM-diI (Sigma)
for 15 min on ice. Cells were then pelleted and washed with PBS 3 3
15 min, with cells being spun and pelleted between washes to remove any
nonbound diI. Eggs at stage HH16–17 were windowed, and a small opening
was made in the external embryonic membranes to allow access to the peri-
cardial cavity. Using a pump ejector, Scx PEO cells were injected into the
pericardial cavity surrounding the surface of the heart. Therefore, only the
external surface of the heart was exposed to the murine PEO cells. After
a 72 hr reincubation period, chick embryos were harvested into cold PBS
and then transferred immediately into 30% sucrose and embedded in
OCT. Cryosections of 10–20 um were treated with an anti-Pecam and anti-
Nfatc1 antibody according to method described above (see Immunostain-
ing). For transplantation of Sema3D-expressing cells, whole proepicardia
were isolated from E9.5 Sema3DGFPCre+; Z/EG mice. Two propepicardia
were placed into the pericardial cavity of each chick embryo adjacent to
the chick proepicardium. The staging and timing of the transplants was the
same as described above.Endothelial Cell Culture
ScxGFP+ and GFP mouse proepicardial cells were isolated as described
above (see Mouse-to-Chick Proepicardial Transplants). Immediately after
FACS sorting, the GFP+ and GFP fractions were collected and each fraction
was plated separately in chamber slides pretreated with 0.1% gelatin. Cells
were cultured in the following media: DMEM + 10% FBS + 1% Pen-Strep +
50 ng/ml VEGF (R&D Systems, catalog #494-VE-005) + 150 ug/ml endothelial
growth supplement (Sigma, catalog #E2759). Cells were cultured for 7 days,
with media refreshed on day 4. After 7 days, cells were fixed on the slide
with PFA and stained with an anti-Pecam antibody.FACS Analysis
Individual ScxCre;R26Rtdtomato hearts from P0–P7 pups were dissected and
manually titurated in PBS. Tissue was then transferred to dissocation solution
(PBS + 20% fetal bovine serum + Roche Collagenase A 10 mg/ml + Roche
collagenase B 10 mg/ml) and incubated at 37C for 1 hr with manual tituration
at 15-min intervals. Following dissocation, tissue was treated with red blood
cell lysing solution (0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA in ddH20)
and resuspended in PF10 (PBS + 10% fetal bovine serum) for antibody stain-
ing. For labeling with intracellular markers such as Troponin T and smooth
muscle myosin cells were treated with PBS + 0.1% Triton-X for permeabiliza-
tion. Triton-X was not used for membrane markers such as Pecam. For a list
of primary antibodies used in this study see Supplemental Experimental
Procedures. Antibody treated cells were sorted in a FACSAria cell sorter and
analyzed using BDFACS Diva software.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
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